Cart
sales@molnova.com
LSP-249
CAS No. 1801253-04-2
LSP-249( —— )
Catalog No. M23814 CAS No. 1801253-04-2
LSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 67 | In Stock |
|
| 2MG | 38 | In Stock |
|
| 5MG | 61 | In Stock |
|
| 10MG | 92 | In Stock |
|
| 25MG | 187 | In Stock |
|
| 50MG | 305 | In Stock |
|
| 100MG | 500 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLSP-249
-
NoteResearch use only, not for human use.
-
Brief DescriptionLSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.
-
DescriptionLSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorkallikrein
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1801253-04-2
-
Formula Weight431.92
-
Molecular FormulaC24H22ClN5O
-
Purity>98% (HPLC)
-
SolubilityDMSO:31.25 mg/mL?(69.45 mM;?ultrasonic and warming and heat to 60°C)
-
SMILESCc1cc(N)nc(C)c1CNC(c1cc(Cc2ccc3ncc(Cl)cc3c2)ncc1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Andrew Mcdonald, et al. Therapeutic inhibitory compounds. Patent. WO2016011209A1.
molnova catalog
related products
-
Bisacurone
Bisacurone has anti-oxidant, anti-inflammatory, and anti-metastatic activities, it may have a protective effect against ethanol-induced liver injury by suppressing hepatic oxidation and inflammation.
-
Methyl 5,6-dibromo-1...
Methyl 5,6-dibromo-1H-indole-3-carboxylate is a marine derived natural products found in Smenospongia sp.
-
CPX-351
CPX-351 (Vyxeos) is a liposomal encapsulant of cytarabine and Zoerythromycin with potential antitumor activity and can be used in the study of acute myeloid leukemia.
